BlackRock Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$4.51M Buy
366,767
+217,007
+145% +$2.81M ﹤0.01% 1185
2016
Q3
$2.21M Buy
149,760
+38,160
+34% +$577K ﹤0.01% 1426
2016
Q2
$1.7M Buy
111,600
+3,492
+3% +$49.4K ﹤0.01% 1510
2016
Q1
$1.4M Buy
108,108
+7,006
+7% +$79.9K ﹤0.01% 1596
2015
Q4
$1.16M Sell
101,102
-46,532
-32% -$531K ﹤0.01% 1641
2015
Q3
$1.63M Buy
147,634
+10,944
+8% +$136K ﹤0.01% 1423
2015
Q2
$1.79M Buy
136,690
+6,928
+5% +$96.6K ﹤0.01% 1323
2015
Q1
$1.91M Buy
129,762
+36,535
+39% +$543K ﹤0.01% 1253
2014
Q4
$1.28M Sell
93,227
-4,591
-5% -$61.5K ﹤0.01% 1361
2014
Q3
$1.2M Sell
97,818
-1,649
-2% -$21.9K ﹤0.01% 1341
2014
Q2
$1.32M Sell
99,467
-10,098
-9% -$134K ﹤0.01% 1334
2014
Q1
$1.4M Buy
109,565
+5,366
+5% +$68.9K ﹤0.01% 1332
2013
Q4
$1.27M Buy
104,199
+7,369
+8% +$94.1K ﹤0.01% 1367
2013
Q3
$1.18M Buy
96,830
+7,393
+8% +$98.7K ﹤0.01% 1350
2013
Q2
$1.28M Buy
+89,437
New +$1.41M ﹤0.01% 1273

Other funds holding MPT

BlackRock Advisors's MPT Position: Q4 2016 in Review

BlackRock Advisors increased its Medical Properties Trust (MPT) stake by 145% in Q4 2016, buying an estimated $2.81M and bringing the position to 366,767 shares worth $4.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1185.

BlackRock Advisors first reported a position in MPT in Q2 2013 and has held it in 15 quarters since. 328 funds tracked by Wall St. Rank hold MPT as of Q4 2016.

  • BlackRock Advisors held 366,767 shares of Medical Properties Trust worth $4.51M as of Q4 2016.
  • BlackRock Advisors bought 217,007 Medical Properties Trust shares in Q4 2016, an estimated $2.81M.
  • Medical Properties Trust made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1185 holding.
  • BlackRock Advisors first reported a position in Medical Properties Trust in Q2 2013 and has held it in 15 quarters since.
  • 328 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.